[HTML][HTML] Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
Oncogene, 2013 - nature.com
Prostate cancer is the second-leading cause of cancer-related mortality in men in Western
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - hero.epa.gov
Prostate cancer is the second-leading cause of cancer-related mortality in men in Western
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
[HTML][HTML] Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate-resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - ncbi.nlm.nih.gov
Prostate cancer is the second-leading cause of cancer-related mortality in men in Western
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
Prostate cancer progression after androgen deprivation therapy: Mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - pure.johnshopkins.edu
Prostate cancer is the second-leading cause of cancer-related mortality in men in Western
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
[PDF][PDF] Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - researchgate.net
The mainstay of therapy for patients with locally advanced prostate cancer, metastatic
prostate cancer and biochemically recurrent disease after failure of localized treatments is …
prostate cancer and biochemically recurrent disease after failure of localized treatments is …
[PDF][PDF] Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - cyberleninka.org
The mainstay of therapy for patients with locally advanced prostate cancer, metastatic
prostate cancer and biochemically recurrent disease after failure of localized treatments is …
prostate cancer and biochemically recurrent disease after failure of localized treatments is …
Prostate cancer progression after androgen deprivation therapy: Mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - jhu.pure.elsevier.com
Prostate cancer is the second-leading cause of cancer-related mortality in men in Western
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
Prostate cancer progression after androgen deprivation therapy: Mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - mdanderson.elsevierpure.com
Prostate cancer is the second-leading cause of cancer-related mortality in men in Western
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
[引用][C] Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - cir.nii.ac.jp
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate
resistance and novel therapeutic approaches | CiNii Research CiNii 国立情報学研究所 学術情報 …
resistance and novel therapeutic approaches | CiNii Research CiNii 国立情報学研究所 学術情報 …
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T Karantanos, PG Corn, TC Thompson - Oncogene, 2013 - go.gale.com
Prostate cancer is the second-leading cause of cancer-related mortality in men in Western
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …
societies. Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer …